Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by investclubon Oct 06, 2020 1:12pm
196 Views
Post# 31674011

RE:Dr. Coombs and Covid

RE:Dr. Coombs and Covid BencrosMum wrote

    Just curious as to why they started their testing with zika virus and sars instead of jumping right into Covid. 
I'm sure there is a reason but it seems a waste of time when the virus we're targeting is the later. 


My interpretation which may be wrong is that it didn't matter all that much because of the way TLD-1433 kills a virus is basically the same so a related virus at the beginning of his research was an indication of how well TLD-1433 would perform. If I remember in the article printed it was stated unlike the usual vaccines developed they had to design them for each virus where as  Dr. COMBS said he felt the vaccine he developed would combat any Coronavirus which if possible would remove an incredible amount of time & expensive on future Coronavirus outbreaks. Dr. Combs did say he had never seen a kill rate as high as TLD-1433 in his tests.
Bullboard Posts